Santen Pharmaceutical Co., Ltd. Stock Börse Stuttgart
Stocks
SZD
JP3336000009
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Börse Stuttgart
22:55:36 11/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 9.650 EUR | +2.12% |
|
-4.46% | +10.92% |
| 08-06 | Santen Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
| 07-27 | Glaukos' Trial of Preserflo MicroShunt Completes Enrollment | MT |
| Market Cap | 554B 3.61B 3.11B 2.94B 2.67B 5B 345B 5.03B 34.95B 13.44B 175B 13.55B 13.25B | P/E 2027 * |
14.3x | P/E 2028 * | 12.7x |
|---|---|---|---|---|---|
| Enterprise Value | 507B 3.3B 2.85B 2.69B 2.44B 4.58B 316B 4.61B 32.01B 12.31B 161B 12.41B 12.13B | EV / Sales 2027 * |
1.67x | EV / Sales 2028 * | 1.53x |
| Free-Float |
96.71% | Yield 2027 * |
2.41% | Yield 2028 * | 2.71% |
| Markets | Quality | ||
|---|---|---|---|
Japan Exchange
| 4536 | Delayed | |
OTC Markets
| SNPHF | Delayed | |
|
Tradegate
| SZD | Real-time | |
|
Deutsche Boerse AG
| SZD | Delayed | |
|
Börse Stuttgart
| SZD | Delayed | |
|
Boerse Muenchen
| SZD | Real-time |
| 29/09/23 | ETF der Woche: Back to the Roots | |
| 28/09/23 | ETF van de week: terug naar de basis | |
| 28/09/23 | L'ETF della settimana: ritorno ai fondamentali | |
| 28/09/23 | ETF de la semaine : Retour aux fondamentaux | |
| 15/02/21 | Nicox S A : A suivre aujourd'hui |
| 1 week | -4.46% | ||
| Current month | -3.02% | ||
| 1 month | -8.10% | ||
| 3 months | -8.10% | ||
| 6 months | +7.82% | ||
| Current year | +10.92% |
| 1 week | 9.4 |  | 9.85 |
| 1 month | 9.4 | | 10.8 |
| 3 years | 7.8 | | 12 |
| 5 years | 6.4 | | 13 |
| Manager | Title | Age | Since |
|---|---|---|---|
Takeshi Ito
CEO | Chief Executive Officer | 67 | 01/09/2022 |
Kazuo Koshiji
DFI | Director of Finance/CFO | - | - |
Daisuke Nakata
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Takeshi Ito
BRD | Director/Board Member | 67 | 23/06/2017 |
Ippei Kurihara
BRD | Director/Board Member | 45 | 01/06/2024 |
Rie Nakajima
BRD | Director/Board Member | 48 | 01/06/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.12% | -4.46% | +2.12% | +9.66% | 3.61B | |
| -0.65% | -2.93% | +47.70% | +86.30% | 994B | |
| -0.29% | -3.51% | +49.15% | +61.95% | 640B | |
| +0.83% | +0.26% | +17.76% | +70.10% | 454B | |
| -0.38% | -3.59% | +30.13% | +34.14% | 337B | |
| -0.09% | -13.54% | +13.34% | +24.74% | 261B | |
| -0.43% | -2.48% | -0.73% | +10.64% | 246B | |
| -1.34% | -13.70% | +36.53% | +46.70% | 204B | |
| -3.44% | -7.51% | -20.63% | -58.97% | 190B | |
| -0.75% | -4.82% | +25.46% | +85.90% | 178B | |
| Average | -0.73% | -5.76% | +20.08% | +37.12% | 389.42B | |
| Weighted average by Cap. | -0.51% | -4.42% | +30.93% | +54.61% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 304B 1.98B 1.71B 1.62B 1.46B 2.75B 189B 2.76B 19.18B 7.38B 96.22B 7.43B 7.27B | 313B 2.04B 1.75B 1.66B 1.51B 2.82B 195B 2.84B 19.73B 7.59B 98.96B 7.65B 7.48B |
| Net income | 38.22B 249M 214M 203M 184M 345M 23.77B 347M 2.41B 927M 12.09B 935M 914M | 40.85B 266M 229M 217M 197M 369M 25.41B 371M 2.58B 991M 12.93B 999M 977M |
| Net Debt | -46.74B -304M -262M -248M -225M -422M -29.07B -424M -2.95B -1.13B -14.79B -1.14B -1.12B | -75.89B -494M -426M -403M -365M -685M -47.21B -689M -4.79B -1.84B -24.02B -1.86B -1.81B |
| Date | Price | Change |
|---|---|---|
| 11/09/26 | €9.650 | +2.12% |
| 10/09/26 | €9.450 | -1.05% |
| 09/09/26 | €9.550 | -1.55% |
| 08/09/26 | €9.700 | -1.52% |
| 07/09/26 | €9.850 | -2.48% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4536 Stock
- SZD Stock
Select your edition
All financial news and data tailored to specific country editions
